ResearcherActive in the last 2 years

Peng Xu

Provisional: name only (low confidence, 0.40), identity_conf@1As of 8 November 2026

Known by name only; no external author ID or institution yet. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 1

Papers, trials and grants by year

2024: 1 paper

Papers 1

Oncogenic CD44 is required for pancreatic cancer cell tumorigenesis and CD44 gene knockout is a new strategy for targeted pancreatic cancer therapy Last author DOI 10.21203/rs.3.rs-3677039/v1 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Quansheng Zhou · 1 shared paper, 2024 · strength 0.21
- Paper Oncogenic CD44 is required for pancreatic cancer cell tumorigenesis and CD44 gene knockout is a new strategy for target… DOI 10.21203/rs.3.rs-3677039/v1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.